American College of Cardiology

OCTOBER 9, 2024

What are the outcomes of bivalirudin vs. heparin anticoagulation during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI)?

STEMI 50

STEMI Myocardial Infarction Outcomes Article 50

American College of Cardiology

MAY 23, 2024

What is the prognostic significance of various microvascular injury (MVI) patterns after ST-segment elevation myocardial infarction (STEMI)?

STEMI 73

STEMI Myocardial Infarction Article 73

Journal of Cardiothoracic Surgery

MARCH 29, 2024

Accurately predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains a complex and critic.

Myocardial Infarction 52

Myocardial Infarction STEMI Research 52

American College of Cardiology

SEPTEMBER 18, 2024

What are long-term clinical benefits of complete versus culprit-only revascularization among ST-segment elevation myocardial infarction (STEMI) patients aged ≥75 years?

STEMI 55

STEMI Myocardial Infarction Article 55

American College of Cardiology

FEBRUARY 12, 2024

The MULTISTARS AMI (MULTivessel Immediate versus STAged RevaScularization in Acute Myocardial Infarction) trial compared immediate versus delayed percutaneous coronary intervention (PCI) of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) who underwent successful primary PCI of the culprit lesion.

Myocardial Infarction 62

Myocardial Infarction STEMI Article 62

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background The diagnosis of a left ventricular (LV) thrombus in patients with ST-segment elevation myocardial infarction (STEMI) remains challenging. Methods We retrospectively evaluated 337 consecutive STEMI patients. The sensitivity for thrombus formation of the first and second TTE was 5.9% and 59%, respectively.

Myocardial Infarction 80

Myocardial Infarction STEMI Hospital 80

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

We developed a user-friendly web application for real-world use, yielding risk scores as a percentage.ConclusionsThe STEMI-ML score effectively predicts in-hospital outcomes in STEMI patients and may assist with risk stratification and individualising patient management.

STEMI 52

STEMI Hospital ICU Outcomes 52

Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 years (±10.9), predominantly male (89.9%).

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Myocardial Infarction 40

Myocardial Infarction STEMI Research 40

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Patients with ST-segment elevation myocardial infarction (STEMI) and complex coronary artery disease (CAD) face a poor prognosis, including increased heart failure (HF) risk. We performed a pooled secondary analysis of 139 patients with STEMI. We performed a pooled secondary analysis of 139 patients with STEMI.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Heart Failure 40

Circulation

NOVEMBER 11, 2024

This study investigates the relationship between baseline 5-HTP levels and the incidence of major adverse cardiovascular events (MACE) in patients who have experienced ST-elevation myocardial infarction (STEMI).Objective:Our years, 53 women) followed for up to 15 years.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Bypass Graft STEMI Angina 40

American College of Cardiology

JUNE 21, 2024

What is the safety and effectiveness of P2Y12 inhibitor pretreatment in patients transferred for primary percutaneous coronary intervention (PPCI) within a regional ST-segment elevation myocardial infarction (STEMI) network?

STEMI 57

STEMI Myocardial Infarction Article 57

All About Cardiovascular System and Disorders

FEBRUARY 6, 2024

STEMI – Anterior Wall ECG shows ST elevation myocardial infarction of anterior wall. Up sloping elevation of ST segment is seen in leads V1 to V5, with maximum ST elevation in V2, as is characteristic of anterior wall infarction. QS complexes are seen from V1 to V3.

STEMI 52

STEMI Myocardial Infarction Aneurysm Electrophysiology 52

American College of Cardiology

OCTOBER 28, 2024

The goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).

STEMI 47

STEMI Myocardial Infarction Article 47

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

Public Health 52

Public Health Myocardial Infarction STEMI Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction Differences in pathophysiology, clinical presentation, and natural course of ST-elevation myocardial infarction in female patients due to either spontaneous dissection (SCAD-STEMI) or atherothrombotic occlusion (type 1 STEMI) have been discussed. vs. 1.8 ± 5.1%, p  = 0.002). vs. 1.8 ± 5.1%, p  = 0.002).

Myocardial Infarction 59

Myocardial Infarction SCAD STEMI Thrombolysis 59

Heart BMJ

JULY 10, 2024

Background Despite restoration of epicardial blood flow in acute ST-elevation myocardial infarction (STEMI), inadequate microcirculatory perfusion is common and portends a poor prognosis. Methods Comprehensive literature search of six electronic databases identified relevant randomised controlled trials.

Myocardial Infarction 52

Myocardial Infarction Thrombolysis STEMI Outcomes 52

Med Page Today

OCTOBER 29, 2024

(MedPage Today) -- The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to findings from the Chinese.

Heart Attack 110

Heart Attack Heart attacks Myocardial Infarction STEMI 110

Circulation

NOVEMBER 11, 2024

A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases. A meta-analysis was performed on primary outcomes of major adverse cardiac events (MACE) and all-cause mortality.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

Circulation

NOVEMBER 11, 2024

Background:Little is known about the clinical relevance of interleukin (IL)-6 and the severity of patients with acute ST-elevation myocardial infarction (STEMI). Blood samples for biomarker analyses, including IL-6, were collected.Results:There were 64 consecutive STEMI patients. There was 75% of males.

STEMI 40

STEMI Myocardial Infarction Tricuspid Biomarkers 40

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Background Despite the crucial role of Chest pain centers (CPCs) in acute myocardial infarction (AMI) management, China's mortality rate for ST-segment elevation myocardial infarction (STEMI) has remained stagnant. Conclusion CPC quality control metrics affect STEMI mortality based on Killip class.

Myocardial Infarction 59

Myocardial Infarction Chest Pain COVID-19 Catheterization Laboratory 59

American College of Cardiology

JUNE 5, 2024

What is the impact of the administration of cangrelor at reperfusion on myocardial infarct (MI) size and microvascular obstruction (MVO) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI)?

STEMI 44

STEMI Myocardial Infarction Article 44

Coronary Artery Disease Journal

OCTOBER 30, 2023

Introduction Elevated peak cardiac troponin levels have been linked with increased morbidity and mortality in patients with acute myocardial infarction (AMI). Results Among the 277 patients diagnosed with AMI who underwent IPF testing, 113 had (STEMI) and 164 had (NSTEMI). Notably, among STEMI patients, those with IPF ≥ 4.2%

Myocardial Infarction 52

Myocardial Infarction STEMI 52

Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients.

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Article Outcomes 59

Open Heart

JANUARY 29, 2024

Objectives This study aimed to perform a meta-analysis of the short-term impact of ischaemic postconditioning (IPoC) on myocardial injury in ST elevation myocardial infarction (STEMI) using surrogate cardiac biomarkers. These results resonate with some studies using imaging techniques to ascertain myocardial damage.

Myocardial Infarction 52

Myocardial Infarction STEMI Article Biomarkers 52

Open Heart

SEPTEMBER 13, 2024

We aimed to investigate gut leakage markers and their associations with inflammation, infarct size and cardiac function. Methods We examined 61 ST-elevation myocardial infarction (STEMI) patients who developed acute HF within 48 hours of successful percutaneous coronary intervention (PCI). to 264.65).

Myocardial Infarction 52

Myocardial Infarction Cardiac Function Heart Failure STEMI 52

Becker's Hospital Review - Cardiology

OCTOBER 8, 2024

The Society of Cardiovascular Angiography and Interventions has published an expert consensus statement on the management of patients with ST-elevation myocardial infarction.

STEMI 52

STEMI Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

MAY 24, 2024

BackgroundST-segment elevation myocardial infarction (STEMI) persists to be prevalent in the elderly with a dismal prognosis. Nevertheless, the influence of aging on the functionality of EPCs in STEMI is not fully understood.MethodThis study enrolled 20 younger STEMI patients and 21 older STEMI patients.

Myocardial Infarction 52

Myocardial Infarction STEMI Thrombolysis 52

Dr. Smith's ECG Blog

OCTOBER 30, 2023

A 60 yo with 2 previous inferior (RCA) STEMIs, stented, called 911 for one hour of chest pain. Here is his most recent previous ECG: This was recorded after intervention for inferior STEMI (with massive ST Elevation, see below), and shows inferior Q-waves with T-wave inversion typical of completed inferior OMI. ng/mL (quite large).

STEMI 112

STEMI Heart Failure Stents Stent 112

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Early ventricular tachycardia/fibrillation (VT/VF) in patients with ST-elevation myocardial infarction (STEMI) has higher morbidity and mortality. This study examines gender-differentiated risk factors and underlying mechanisms for early onset VT/VF in STEMI. vs. 61.0 ± 13.0 vs. 1.70 ± 0.28, P  = 0.02

Myocardial Infarction 59

Myocardial Infarction STEMI Defibrillator Diet 59

Cardiovascular Diabetology

DECEMBER 5, 2023

Stress hyperglycemia ratio (SHR), associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), has several definitions. This study aims to assess the prognostic value o.

Myocardial Infarction 45

Myocardial Infarction STEMI Outcomes Research 45

Coronary Artery Disease Journal

JUNE 10, 2024

Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. The contemporary incidence, mortality, and management of post-STEMI VSR remains unclear. and 10 ± 1.2%

Myocardial Infarction 40

Myocardial Infarction STEMI Outcomes Inpatient 40

Open Heart

JANUARY 27, 2023

Background ST elevation myocardial infarction (STEMI) represents a cardiac emergency. Inferior STEMI represents a dilemma for cardiologists. Methods We performed a single-centre retrospective cohort analysis of all patients admitted to our hospital from 2008 to 2020 with a diagnosis of inferior STEMI.

STEMI 52

STEMI Myocardial Infarction Hospital 52

Heart BMJ

JANUARY 29, 2024

Objectives To ascertain whether invasive assessment of coronary physiology soon after recanalisation of the culprit artery by primary percutaneous coronary intervention is associated with the development of microvascular obstruction by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction Physiology STEMI 40

Circulation

NOVEMBER 11, 2024

Introduction:Elevated LDL cholesterol is linked to microvascular injury and adverse cardiac events in STEMI patients. This study examines the impact of prior statin use on LDL levels at the time of MI, focusing on NSTEMI and STEMI patients. For STEMI, the treated group had an average LDL level of 87.8 ± 42 mg/dL versus 103 ± 41.2

STEMI 40

STEMI Cholesterol Myocardial Infarction Document 40

Medical Xpress - Cardiology

OCTOBER 11, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI.

Myocardial Infarction 40

Myocardial Infarction STEMI 40

Open Heart

AUGUST 17, 2023

Background Tocilizumab improves myocardial salvage index (MSI) in patients with ST-elevation myocardial infarction (STEMI), but its mechanisms of action are unclear. Methods STEMI patients were randomised to receive a single dose of 280 mg tocilizumab (n=101) or placebo (n=98) before percutaneous coronary intervention.

Myocardial Infarction 52

Myocardial Infarction STEMI 52